| Phase 4 |
| NCT03753555 |
The Effect of InTensive Statin in Ischemic Stroke With inTracranial Atherosclerotic… |
Stroke, Ischemic |
Recruiting |
| Phase 3 |
| NCT05855200 |
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III… |
Colonic Neoplasms |
Recruiting |
| NCT04495088 |
Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With… |
Rectal Cancer |
Recruiting |
| NCT07459296 |
Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC |
Nasopharyngeal Carcinoma (NPC) |
Recruiting |
| NCT06497985 |
A Study of Tucidinostat in Combination With Sintilimab and Bevacizumab in MSS/pMMR… |
Colorectal Cancer |
Recruiting |
| NCT06346197 |
Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric… |
Gastric Cancer |
Recruiting |
| NCT05357846 |
PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally… |
Squamous Cell Esophageal Carcinoma |
Recruiting |
| NCT06618664 |
A Clinical Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab… |
Advanced Hepatocellular Carcinoma |
Recruiting |
| NCT07306663 |
Sintilimab Combined With Chemotherapy Induction Therapy Followed by CCRT vs. CCRT for… |
Esophageal Cancer |
Active, Not Recruiting |
| NCT05171660 |
Combination With Sintilimab and XELOX+Bevacizumab as 1st Line Therapy in RAS-mutant… |
Colorectal Cancer Stage IV |
Active, Not Recruiting |
| NCT07537946 |
Local Consolidation After Sintilimab Plus Lenvatinib for Metastatic Liver Cancer |
Hepatocellular Carcinoma (HCC) |
Not Yet Recruiting |
| NCT05890742 |
A Clinical Trial Evaluating the Efficacy and Safety of IBI310 in Combination With… |
MSI-H |
Active, Not Recruiting |
| Phase 2/3 |
| NCT07490262 |
A Study to Evaluate the Efficacy and Safety of IBI310 and Sintilimab Combination Therapy… |
Hepatocellular Carcinoma (HCC) |
Recruiting |
| NCT07643623 |
Neoadjuvant and Adjuvant Therapy Studies of Sintilimab Combined With Chemotherapy With or… |
Resectable Gastric/Gastroesophageal Junction Adenocarcinoma |
Not Yet Recruiting |
| Phase 2 |
| NCT07120698 |
Adaptive Adjuvant Sintilimab Therapy Guided by MRD (ADAPT Lung) |
NSCLC (Non-small Cell Lung Cancer) |
Recruiting |
| NCT07077512 |
Relmacabtagene Autoleucel Combined With Sintilimab for Relapsed/Refractory B-cell Lymphoma |
Large B Cell Diffuse Lymphoma |
Recruiting |
| NCT07400302 |
Sintilimab Combined With Chemotherapy for Adjuvant Treatment of Mucosal Melanoma After… |
Mucosal Melanoma |
Recruiting |
| NCT07468630 |
Tolecizumab Plus Chemoimmunotherapy for pMMR/MSS Locally Advanced Colon Adenocarcinoma |
Colon Adenocarcinoma |
Recruiting |
| NCT07492615 |
A Clinical Study of Sintilimab Combined With Chemothrapy Versus Chemotherapy as Adjuvant… |
Gastric Cancer or Gastroesophageal Junction Adenocarcinoma |
Recruiting |
| NCT07506109 |
A Phase II Study of Sintilimab Combined With Ipilimumab N01, Cetuximab and Dabrafenib in… |
BRAF V600E |
Recruiting |
| NCT07518602 |
Efficacy and Safety of Chidamide+Sintilimab+Bev as Second-Line Therapy in Advanced… |
Extrapulmonary Neuroendocrine Carcinoma (EP-NEC) |
Recruiting |
| NCT03872661 |
Neoadjuvant IBI308, Bevacizumab, Plus Pemetrexed and Carboplatin Followed by Surgery in… |
Lung Cancer Stage III |
Recruiting |
| NCT06860490 |
HAIC Combined With Sintilimab Plus Bevacizumab Biosimilar for Advanced Hepatocellular… |
Hepatocellular Carcinoma (HCC) |
Recruiting |
| NCT06204094 |
Node-sparing Radiotherapy Combined With Total Neoadjuvant CAPOX and Sintilimab for MSS… |
Locally Advanced Rectal Cancer |
Recruiting |
| NCT07309952 |
Neoadjuvant SBRT Followed by Sintilimab Plus Chemotherapy for N3-Positive NSCLC |
Locally Advanced Non-Small Cell Lung Cancer |
Recruiting |